European Organisation for #Research and #Treatment of #Cancer defines better treatments for all cancer #patients to prolong survival and improve quality of life
Europe
- Tweets 3,906
- Following 698
- Followers 16,197
- Likes 3,213
📅 Save the date!
EORTC events are back in 2026 ⬇️
#CancerResearch #ClinicalTrials #Oncology #EORTCevents
1
1
9
2,043
📢 Late rate ends 4 November!
Join the international oncology research community at #ENASymp26.
⏰ Register now: event.eortc.org/ena2026/regi…
@AACR @theNCI
#CancerResearch #Oncology
1
156
We're hiring a Junior Clinical Operations Manager at EORTC.
Help support the planning, coordination and execution of international clinical studies that advance cancer treatment.
📍Brussels, Belgium
👉 Apply here: eortc.org/job/junior-clinica…
#Hiring #ClinicalResearch #EORTC
241
📘 How can researchers better involve patients & caregivers in #QualityofLife research?
The new Guidance for Patient Involvement in the @EORTC_QLG offers practical recommendations & resources to support meaningful patient involvement.
🔗 qol.eortc.org/manual/guidanc…
#CancerResearch
2
2
289
EORTC retweeted
👏 Proud to see the @EORTC Quality of Life Group featured at the 27th Panhellenic Urology Congress.
By showcasing the EORTC HRQoL measurement system & the QLQ-RCC38 module development, we continue to promote the value of PROs & #QualityofLife research in #CancerCare.
@ISUReHub
2
4
174
🎗️ What quality of life issues matter most to people living with metastatic breast cancer?
This joint study from the EORTC #QualityofLife and #BreastCancer Groups identified key patient priorities and supports development of the EORTC QLQ‑MBR module.
🔗 eortc.org/publications/
4
303
The first participating site is now active in #EORTC STARBURST-1. Led by Prof Alexandra Masson-Lecomte and involving 20 centres, this study will investigate mpMRI, NacVI-RADS, tumour DNA and molecular classifications in muscle-invasive bladder cancer.
🔗 eortc.org/blog/2026/10/28/fs…
2
6
555
🌍An important EORTC #QualityofLife Group publication led by @csimoes96 and colleagues, proposing a flexible and actionable approach to HRQoL assessment in people diagnosed with solid rare cancers. 👇
#CancerResearch #RareCancers #GivingVoice2Patients @Winette_vdGraaf @OlgaHusson
🔍 New @EORTC #QualityofLife Group publication.
In 397 patients across 20 solid rare cancer diagnoses, the EORTC QLQ‑C30 proved relevant for assessing HRQoL, and combining it with tailored item lists may better capture what matters most to patients.
🔗 eortc.org/publications/
2
307
#ESMO26 concluded yesterday after five days of scientific exchange across the oncology community.
Catch up on the key EORTC studies, presentations and highlights from this year's congress ⬇️
🔗 eortc.org/blog/2026/10/27/eo…
#EORTC #CancerResearch @myESMO
2
5
412
EORTC retweeted
📌 #ESMO26 e-poster spotlight
“Are we measuring the symptoms that matter most to patients? Our analysis shows that existing @EORTC questionnaires capture most common treatment-related symptoms in #HeadNeckCancer.”
Congrats to @mkmoutafi et al. 👏
#GivingVoice2Patients @myESMO
2
7
236
📌 #ESMO26 Poster
How comparable are PFS results across cancer trials?
A systematic review of 156 oncology studies found considerable variation in how intercurrent events were handled & reported, highlighting the need for greater standardisation & transparency.
#CancerResearch
1
11
531
Come and meet us at booth S1041, Hall 10 👋
Find out how to submit your research to #EORTCSummit, explore EORTC membership and discover all the opportunities to get involved in our clinical research. #ESMO26
📢 Call for Abstracts is OPEN for #EORTCSummit 2027!
Submit your research and share it with the clinical cancer research community.
📅 Abstract submission: 30 September – 4 November 2026
👉 event.eortc.org/summit/abstr…
#CancerResearch #ClinicalResearch #Oncology
1
3
258
📄 New in @Hemasphere_EHA
Researchers from the i-BFM Study Group, including contributors from EORTC, identified favorable subgroups of pediatric high-hyperdiploid ALL in a retrospective multinational study that included data from the EORTC-CLG 58951 trial.
doi.org/10.1002/hem3.70477
2
276
#ESMO26 Congress opens tomorrow in Madrid.
EORTC researchers and collaborators will present multidisciplinary research across oral presentations, mini orals, posters, e-posters and trials in progress.
Explore our abstract overview: eortc.org/blog/2026/10/22/eo…
2
3
433
👏 Proud of the strong contribution from the EORTC Quality of Life Group at #ISOQOL 2026, showcasing research that helps strengthen patient-centred cancer care and gives greater visibility to patients' experiences.
👇
#QualityofLife #GivingVoice2Patients #CancerResearch
@ISOQOL
📢 New questionnaires, interpretation guidelines, survivorship tools, paediatric oncology research & initiatives to improve the use of PROs: discover the key @EORTC #QualityofLife Group research presented at #ISOQOL 2026.
🔗 eortc.org/blog/2026/10/21/eo…
#GivingVoice2Patients
@ISOQOL
2
10
447
🎀 #PinkOctober: Can genomic testing help avoid unnecessary chemotherapy in breast cancer? Meet Betty, a participant in the MINDACT study.
Learn more: eortc.org/blog/2026/10/07/pi…
🎥 Watch her story:
@JulesBordet
#MINDACT #EORTCbreast
3
299
EORTC retweeted
📖 Yesterday afternoon at #ISOQOL, @monika_sztankay presented the @EORTC Patient-Reported Outcome Interpretation Guideline.
The project also introduces new resources to help patients understand EORTC PRO data, coming soon on our website.
#GivingVoice2Patients #QualityofLife
2
9
237
What does it take to move from protocol to patient?
Today at @EANM_NucMed 2026, our past president, @Winette_vdGraaf, shared practical lessons from multinational academic clinical trials across Europe drawing on years of experience in international cancer research.
#EANM26
3
314